Fertility-Centered Kindbody Adds Genetic Testing with Acquisition of Phosphorus Labs

Fertility Company Kindbody announced Tuesday that it will bring home genetic testing with the acquisition of Phosphorus Labs.

The agreement will provide Kindbody with a reference lab in Sekkas, NJ, as well as phosphorus staff of geneticists and lab technicians who will join the new KindLab division of Fertility Startup.

This acquisition is Kindbody’s second in 2022. Acquire Vios Fertility Institute, a network of fertility clinics.

“I am thrilled to welcome the Phosphorus team into the Kindbody family. With KindLabs, our patients will experience a seamless integration of high-quality genetic testing services,” said Dr. Dean Morbeck, Kindbody’s chief scientific officer, in a statement.

“In addition to bringing in existing in-house diagnostic testing, KindLabs enables us to further our goal of improving patient experience and outcomes by controlling our costs and developing and integrating new diagnostic solutions.”

Why it matters

Kindbody says it will begin testing its own genetics later this year. Prior to the purchase, the company outsourced pre-implantation genetic testing for aneuploidy – screening the fetus for extra or missing chromosomes during IVF – and expanded carrier screening for genes that could cause the disorder.

“This acquisition allows us to incorporate Genomics into our day-to-day patient care, helping KindBody build healthy families now and in the future. I am delighted to welcome this team to KindLabs and I am honored to work with this talented team,” said Kindbody Chief Genomics. Officer Amber Cooper said in a statement.

Greater trend

Earlier this year, Kindbody Introduced a line of home fertility hormone tests for men and women. The Fertility Startup raised $ 62 million from the Series C fund almost a year ago and $ 32 million in Series B funding in 2020.

Other companies in the fertility space include male-centered startup Legacy, which has recently been raised. 25 million; Direct-to-Consumer Virtual Care Company Ro, which has acquired both Dadi and Modern Fertility; And Prove, which raised $ 9.7 million at the end of last year.

Recently, Tia, a provider of women’s hybrids Announces the expansion of fertility services, including fertility testing, counseling and care plans, as well as advice on their options for pregnant patients.

Leave a Reply

Your email address will not be published.